Urovant Sciences GmbH (Switzerland)
Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2020
Urovant and Sunovion announce vibegron co-promotion agreement
Urovant Sciences announced a five-year U.S. co-promotion agreement with Sunovion Pharmaceuticals to promote vibegron to primary care physicians and patients, contingent on FDA approval. Sunovion is to provide related sales and marketing activities through March 31, 2026.
2020
Urovant appoints James Hindman to its board
Urovant Sciences announced the appointment of James Hindman to its board of directors.